| Randall Gerald Trudell, MD | |
|
2200 Sutherland Ave., Knoxville, TN 37919 | |
| (865) 521-6174 | |
| Not Available |
| Full Name | Randall Gerald Trudell |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 45 Years |
| Location | 2200 Sutherland Ave., Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083684724 | NPI | - | NPPES |
| 3015861 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 16509 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Tn Medical Center | Knoxville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Health System, Inc. | 5294646378 | 526 |
News Archive
Antibodies play a fundamental role in medicine, and antibody-mediated immune response is the ultimate target in the quest for a vaccine to defeat the current pandemic.
Yesterday, during a meeting of the Executive Appropriations Committee of the Utah State Legislature, lawmakers unanimously approved $90 million in funding for the Utah Translational Research Building at the University of Utah Huntsman Mental Health Institute.
Affymetrix, Inc. and ScreenCell, a privately-held company, today announced the signing of a worldwide distribution agreement for ScreenCell's isolation devices and dilution buffers, designed for the collection of Circulating Tumor Cells (CTCs) in peripheral blood.
The latest generation of genomic tests for breast cancer can improve physicians' ability to diagnose the disease and more precisely tailor each patient's treatment, according to a study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). The study examined the first commercially available genomic tests to determine the molecular subtype of a breast cancer tumor.
In a new study, published on the pre-print server medRxiv, an international team of researchers found that a one-dose policy may increase the potential for antigenic evolution. The study revealed that focusing on one dose may decrease infections in the short term, but longer-term outcomes rely on this immune strength.
› Verified 6 days ago
| Entity Name | University Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
Antibodies play a fundamental role in medicine, and antibody-mediated immune response is the ultimate target in the quest for a vaccine to defeat the current pandemic.
Yesterday, during a meeting of the Executive Appropriations Committee of the Utah State Legislature, lawmakers unanimously approved $90 million in funding for the Utah Translational Research Building at the University of Utah Huntsman Mental Health Institute.
Affymetrix, Inc. and ScreenCell, a privately-held company, today announced the signing of a worldwide distribution agreement for ScreenCell's isolation devices and dilution buffers, designed for the collection of Circulating Tumor Cells (CTCs) in peripheral blood.
The latest generation of genomic tests for breast cancer can improve physicians' ability to diagnose the disease and more precisely tailor each patient's treatment, according to a study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). The study examined the first commercially available genomic tests to determine the molecular subtype of a breast cancer tumor.
In a new study, published on the pre-print server medRxiv, an international team of researchers found that a one-dose policy may increase the potential for antigenic evolution. The study revealed that focusing on one dose may decrease infections in the short term, but longer-term outcomes rely on this immune strength.
› Verified 6 days ago
| Entity Name | Knoxville Neurology Clinic, P.l.l.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992775605 PECOS PAC ID: 7315835527 Enrollment ID: O20040309000819 |
News Archive
Antibodies play a fundamental role in medicine, and antibody-mediated immune response is the ultimate target in the quest for a vaccine to defeat the current pandemic.
Yesterday, during a meeting of the Executive Appropriations Committee of the Utah State Legislature, lawmakers unanimously approved $90 million in funding for the Utah Translational Research Building at the University of Utah Huntsman Mental Health Institute.
Affymetrix, Inc. and ScreenCell, a privately-held company, today announced the signing of a worldwide distribution agreement for ScreenCell's isolation devices and dilution buffers, designed for the collection of Circulating Tumor Cells (CTCs) in peripheral blood.
The latest generation of genomic tests for breast cancer can improve physicians' ability to diagnose the disease and more precisely tailor each patient's treatment, according to a study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). The study examined the first commercially available genomic tests to determine the molecular subtype of a breast cancer tumor.
In a new study, published on the pre-print server medRxiv, an international team of researchers found that a one-dose policy may increase the potential for antigenic evolution. The study revealed that focusing on one dose may decrease infections in the short term, but longer-term outcomes rely on this immune strength.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randall Gerald Trudell, MD 2200 Sutherland Ave., Knoxville, TN 37919 Ph: (865) 521-6174 | Randall Gerald Trudell, MD 2200 Sutherland Ave., Knoxville, TN 37919 Ph: (865) 521-6174 |
News Archive
Antibodies play a fundamental role in medicine, and antibody-mediated immune response is the ultimate target in the quest for a vaccine to defeat the current pandemic.
Yesterday, during a meeting of the Executive Appropriations Committee of the Utah State Legislature, lawmakers unanimously approved $90 million in funding for the Utah Translational Research Building at the University of Utah Huntsman Mental Health Institute.
Affymetrix, Inc. and ScreenCell, a privately-held company, today announced the signing of a worldwide distribution agreement for ScreenCell's isolation devices and dilution buffers, designed for the collection of Circulating Tumor Cells (CTCs) in peripheral blood.
The latest generation of genomic tests for breast cancer can improve physicians' ability to diagnose the disease and more precisely tailor each patient's treatment, according to a study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). The study examined the first commercially available genomic tests to determine the molecular subtype of a breast cancer tumor.
In a new study, published on the pre-print server medRxiv, an international team of researchers found that a one-dose policy may increase the potential for antigenic evolution. The study revealed that focusing on one dose may decrease infections in the short term, but longer-term outcomes rely on this immune strength.
› Verified 6 days ago
Bertram R Henry, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 214 S Peters Rd, 101, Knoxville, TN 37923 Phone: 865-539-1001 Fax: 865-693-6393 | |
Dr. Namita Garg, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2018 W Clinch Avenue, Knoxville, TN 37916 Phone: 865-523-5437 Fax: 865-523-3559 | |
Michelle Lanter Brewer, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2200 Sutherland Ave., Knoxville, TN 37919 Phone: 865-521-6174 | |
Dr. Caryn Leslie Stoller, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1111 N Northshore Dr Ste S490, Knoxville, TN 37919 Phone: 865-584-0171 Fax: 865-584-0174 | |
Sharon R Burnside, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6906 Kingston Pike, Suite 200, Knoxville, TN 37919 Phone: 865-588-4044 | |
Manju Khanna, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Arthur St, Knoxville, TN 37921 Phone: 865-523-8695 | |
Dr. Raymond L Paine, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9401 Park West Blvd, Knoxville, TN 37923 Phone: 865-690-8190 Fax: 865-531-3536 |